Tarbox Family Office, Inc. Regenxbio Inc. Transaction History

Tarbox Family Office, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 12, 2021	SELL	$29.09 - $45.68 $29,090 - $45,680	-1,000 Closed	0 $0
Q2 2021 Jul 16, 2021	BUY	$32.46 - $40.48 $31,843 - $39,710	981 Added 5163.16%	1,000 $39,000
Q4 2020 Jan 27, 2021	BUY	$26.52 - $49.35 $503 - $937	19 New	19 $1,000
Q3 2020 Oct 22, 2020	SELL	$27.01 - $40.26 $783 - $1,167	-29 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$27.75 - $43.44 $499 - $781	18 Added 163.64%	29 $1,000
Q1 2020 Apr 30, 2020	SELL	$21.5 - $54.2 $774 - $1,951	-36 Reduced 76.6%	11 $0
Q4 2019 Jan 31, 2020	BUY	$34.54 - $44.87 $1,623 - $2,108	47 New	47 $2,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.